Medartis Holding Ag Stock Net Income

MED Stock   93.20  5.00  5.67%   
As of the 19th of February, Medartis Holding secures the Downside Deviation of 2.04, risk adjusted performance of 0.1326, and Mean Deviation of 1.7. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Medartis Holding, as well as the relationship between them. Please verify Medartis Holding coefficient of variation, maximum drawdown, skewness, as well as the relationship between the information ratio and downside variance to decide if Medartis Holding AG is priced some-what accurately, providing market reflects its recent price of 93.2 per share.

Medartis Holding Total Revenue

158.24 Million

Medartis Holding's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Medartis Holding's valuation are provided below:
Gross Profit
187 M
Profit Margin
(0)
Market Capitalization
1.2 B
Enterprise Value Revenue
4.6539
Revenue
236.3 M
There are over one hundred nineteen available fundamental ratios for Medartis Holding, which can be analyzed over time and compared to other ratios. All traders should should check Medartis Holding's last-minute fundamental trends against the trends from 2010 to 2026 to make sure the company is sustainable. Market Cap is likely to climb to about 630.9 M in 2026. Enterprise Value is likely to climb to about 625.4 M in 2026 This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
Last ReportedProjected for Next Year
Net Income From Continuing Ops3.2 M1.8 M
Net Loss-5.2 M-4.9 M
Net Income3.2 M1.8 M
Net Income Per Share 0.33  0.21 
Net Income Per E B T 1.71  1.79 
Net Income Per E B T is likely to climb to 1.79 in 2026, whereas Net Income From Continuing Ops is likely to drop slightly above 1.8 M in 2026.
  
The evolution of Net Income for Medartis Holding AG provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Medartis Holding compares to historical norms and industry peers.

Latest Medartis Holding's Net Income Growth Pattern

Below is the plot of the Net Income of Medartis Holding AG over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Medartis Holding financial statement analysis. It represents the amount of money remaining after all of Medartis Holding AG operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Medartis Holding's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Medartis Holding's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 3.53 M10 Years Trend
Slightly volatile
   Net Income   
       Timeline  

Medartis Net Income Regression Statistics

Arithmetic Mean3,726,668
Geometric Mean3,496,803
Coefficient Of Variation100.00
Mean Deviation2,923,780
Median3,528,000
Standard Deviation3,726,740
Sample Variance13.9T
Range13.1M
R-Value(0.63)
Mean Square Error9T
R-Squared0.39
Significance0.01
Slope(463,697)
Total Sum of Squares222.2T

Medartis Net Income History

20261.8 M
20253.2 M
20243.5 M
2023619 K
2022-5.8 M
20216.8 M
2020-943.6 K

Medartis Net Income Driver Correlations

Understanding the fundamental principles of building solid financial models for Medartis Holding is extremely important. It helps to project a fair market value of Medartis Stock properly, considering its historical fundamentals such as Net Income. Since Medartis Holding's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Medartis Holding's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Medartis Holding's interrelated accounts and indicators.
Understanding that Medartis Holding's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Medartis Holding represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Medartis Holding's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.

Medartis Holding 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Medartis Holding's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Medartis Holding.
0.00
11/21/2025
No Change 0.00  0.0 
In 2 months and 31 days
02/19/2026
0.00
If you would invest  0.00  in Medartis Holding on November 21, 2025 and sell it all today you would earn a total of 0.00 from holding Medartis Holding AG or generate 0.0% return on investment in Medartis Holding over 90 days. Medartis Holding is related to or competes with COSMO Pharmaceuticals, Aevis Victoria, SKAN Group, Kuros Biosciences, Idorsia, PolyPeptide Group, and Basilea Pharmaceutica. Medartis Holding is entity of Switzerland More

Medartis Holding Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Medartis Holding's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Medartis Holding AG upside and downside potential and time the market with a certain degree of confidence.

Medartis Holding Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Medartis Holding's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Medartis Holding's standard deviation. In reality, there are many statistical measures that can use Medartis Holding historical prices to predict the future Medartis Holding's volatility.
Hype
Prediction
LowEstimatedHigh
91.3093.5395.76
Details
Intrinsic
Valuation
LowRealHigh
83.88106.18108.41
Details
Naive
Forecast
LowNextHigh
90.9493.1795.39
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.100.130.17
Details

Medartis Holding February 19, 2026 Technical Indicators

Medartis Holding Backtested Returns

Medartis Holding appears to be very steady, given 3 months investment horizon. Medartis Holding has Sharpe Ratio of 0.17, which conveys that the firm had a 0.17 % return per unit of risk over the last 3 months. We have found thirty technical indicators for Medartis Holding, which you can use to evaluate the volatility of the firm. Please exercise Medartis Holding's Risk Adjusted Performance of 0.1326, downside deviation of 2.04, and Mean Deviation of 1.7 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Medartis Holding holds a performance score of 13. The company secures a Beta (Market Risk) of 0.75, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Medartis Holding's returns are expected to increase less than the market. However, during the bear market, the loss of holding Medartis Holding is expected to be smaller as well. Please check Medartis Holding's maximum drawdown, skewness, and the relationship between the total risk alpha and downside variance , to make a quick decision on whether Medartis Holding's current price movements will revert.

Auto-correlation

    
  0.51  

Modest predictability

Medartis Holding AG has modest predictability. Overlapping area represents the amount of predictability between Medartis Holding time series from 21st of November 2025 to 5th of January 2026 and 5th of January 2026 to 19th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Medartis Holding price movement. The serial correlation of 0.51 indicates that about 51.0% of current Medartis Holding price fluctuation can be explain by its past prices.
Correlation Coefficient0.51
Spearman Rank Test0.39
Residual Average0.0
Price Variance7.83
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Competition

Medartis Accumulated Other Comprehensive Income

Accumulated Other Comprehensive Income

345.91 Million

At this time, Medartis Holding's Accumulated Other Comprehensive Income is fairly stable compared to the past year.
Based on the recorded statements, Medartis Holding AG reported net income of 3.53 M. This is 98.97% lower than that of the Health Care Equipment & Supplies sector and 98.52% lower than that of the Health Care industry. The net income for all Switzerland stocks is 99.38% higher than that of the company.

Medartis Net Income Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medartis Holding's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Medartis Holding could also be used in its relative valuation, which is a method of valuing Medartis Holding by comparing valuation metrics of similar companies.
Medartis Holding is currently under evaluation in net income category among its peers.

Medartis Fundamentals

About Medartis Holding Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Medartis Holding AG's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medartis Holding using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medartis Holding AG based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Medartis Stock Analysis

When running Medartis Holding's price analysis, check to measure Medartis Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medartis Holding is operating at the current time. Most of Medartis Holding's value examination focuses on studying past and present price action to predict the probability of Medartis Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medartis Holding's price. Additionally, you may evaluate how the addition of Medartis Holding to your portfolios can decrease your overall portfolio volatility.